Osmotica Drug Patent Portfolio
Osmotica owns 2 orange book drugs protected by 7 US patents Given below is the list of Osmotica's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10265308 | Dose-dumping resistant controlled release dosage form | 03 Feb, 2037 | Active |
| US10695336 | Dose-dumping resistant controlled release dosage form | 03 Feb, 2037 | Active |
| US9707217 | SYSTEMS FOR DETERMINING FAULT LOCATION ON POWER DISTRIBUTION LINES | 03 Feb, 2037 | Active |
| US9827234 | APPARATUS AND METHOD ARRANGED TO PROVIDE CONTROLLABLE WATER TREATMENT CUSTOMIZED TO THE CONDITIONS OF WATER SUPPLIED TO A BEVERAGE DISPENSER | 03 Feb, 2037 | Active |
| US9855258 | Dose-dumping resistant controlled release dosage form | 03 Feb, 2037 | Active |
| US6403120 | Extended release formulation of venlafaxine hydrochloride | 20 Mar, 2017 | Expired |
| US6419958 | Extended release formulation of venlafaxine hydrochloride | 20 Mar, 2017 | Expired |
Latest Legal Activities on Osmotica's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Osmotica.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Year, Large Entity | 20 Jun, 2025 | US9855258 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 14 May, 2025 | US9827234 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 30 Dec, 2024 | US9707217 |
| Entity Status Set To Undiscounted (Initial Default Setting or Status Change) | 30 Oct, 2024 | US9827234 |
| Entity Status Set To Undiscounted (Initial Default Setting or Status Change) | 30 Oct, 2024 | US9855258 |
| Entity Status Set To Undiscounted (Initial Default Setting or Status Change) | 12 Apr, 2024 | US9707217 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 13 Dec, 2023 | US10695336 |
| Entity Status Set To Undiscounted (Initial Default Setting or Status Change) | 18 Sep, 2023 | US10695336 |
| Email Notification | 17 Apr, 2023 | US9827234 |
| Electronic Review | 17 Apr, 2023 | US10265308 |
| Change in Power of Attorney (May Include Associate POA) | 17 Apr, 2023 | US10265308 |
| Change in Power of Attorney (May Include Associate POA) | 17 Apr, 2023 | US9827234 |
| Email Notification | 17 Apr, 2023 | US10265308 |
| Email Notification | 17 Apr, 2023 | US10695336 |
| Electronic Review | 17 Apr, 2023 | US10695336 |
Osmotica's Family Patents
Osmotica Drug List
Given below is the complete list of Osmotica's drugs and the patents protecting them.
1. Relexxii
Relexxii is protected by 5 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10265308 | Dose-dumping resistant controlled release dosage form |
03 Feb, 2037
(10 years from now)
| Active |
| US10695336 | Dose-dumping resistant controlled release dosage form |
03 Feb, 2037
(10 years from now)
| Active |
| US9707217 | SYSTEMS FOR DETERMINING FAULT LOCATION ON POWER DISTRIBUTION LINES |
03 Feb, 2037
(10 years from now)
| Active |
| US9827234 | APPARATUS AND METHOD ARRANGED TO PROVIDE CONTROLLABLE WATER TREATMENT CUSTOMIZED TO THE CONDITIONS OF WATER SUPPLIED TO A BEVERAGE DISPENSER |
03 Feb, 2037
(10 years from now)
| Active |
| US9855258 | Dose-dumping resistant controlled release dosage form |
03 Feb, 2037
(10 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Relexxii's drug page
2. Venlafaxine Hydrochloride
Venlafaxine Hydrochloride is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6403120 | Extended release formulation of venlafaxine hydrochloride |
20 Mar, 2017
(8 years ago)
| Expired |
| US6419958 | Extended release formulation of venlafaxine hydrochloride |
20 Mar, 2017
(8 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Venlafaxine Hydrochloride's drug page